Estrogen activates phosphatases and antagonizes growth-promoting effect of angiotensin II

Hypertension

Volumn 39, Issue 1, 2002, Pages 41-45

  Takeda Matsubara, Yuko ^a   Nakagami, Hironori ^a   Iwai, Masaru ^a   Cui, Tai Xing ^a   Shiuchi, Tetsuya ^a   Akishita, Masahiro ^b   Nahmias, Clara ^c   Ito, Masaharu ^a   Horiuchi, Masatsugu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYORIN UNIVERSITY   (Japan)

^c INSTITUT COCHIN   (France)

Author keywords

Angiotensin II; Estrogen; Receptors, angiotensin II; Signal transduction; Vasculature

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; DACTINOMYCIN; ESTRADIOL; ESTROGEN; MITOGEN ACTIVATED PROTEIN KINASE; OKADAIC ACID; PHOSPHATASE; VANADIC ACID;

ANIMAL CELL; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME INDUCTION; HEART PROTECTION; INTIMA; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; CELL CYCLE PROTEINS; CELL DIVISION; CELLS, CULTURED; DRUG INTERACTIONS; ENZYME ACTIVATION; ESTRADIOL; IMMEDIATE-EARLY PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MUSCLE, SMOOTH, VASCULAR; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN-TYROSINE-PHOSPHATASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR CROSS-TALK; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; RECEPTORS, ESTROGEN; SHP1 PROTEIN TYROSINE PHOSPHATASE;

EID: 0036153198     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/hy1201.097197     Document Type: Article

References (21)

1. Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the Nurses' Health Study
2. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoprotein
3. Estrogen regulation of angiotensin-converting enzyme mRNA
4. 1 receptor gene expression in vitro and in vivo
5. Intracellular third loop domain of angiotensin II type-2 receptor: Role in mediating signal transduction and cellular function
6. 2 receptors, regulates STAT activation by negative crosstalk
7. 2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth
8. Identification of a domain in the angiotensin II type 1 receptor determining Gq coupling by the use of receptor chimeras
9. 2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell
10. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase
11. Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis
12. Growth factors and mitogen-activated protein kinases
13. Estradiol inhibits smooth muscle cell growth in part by activating the cAMP-adenosine pathway
14. Reduced MAP kinase phosphatase-1 degradation after p42/p44 MAPK-dependent phosphorylation
15. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo
16. Differential effects of 17β-estradiol on mitogen-activated protein kinase pathways in rat cardiomyocytes
17. 2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells: Phosphatidic acid activates receptor dephosphorylation by PTP1C
18. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals
19. The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling
20. Estrogen hits the surface
21. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system